RESUMEN
In this study we investigated, for the first time in vivo, the effect of cloricromene, a cumarine derivative, on NF-kappaB activation in endotoxin-treated rats. Endotoxemia was induced in male rats by the intravenous injection of Salmonella typhosa lipopolysaccharide (LPS; 2 mg/kg/i.v.). In vivo treatment with cloricromene (2 mg/kg/i.v.) 30 min before lipopolysaccharide administration reversed the LPS-induced loss in tone of the aortic rings, improved their reactivity to phenylephrine, decreased both nitric oxide (NO) and TNF-alpha serum levels by inhibiting LPS-induced inducible NO synthase and TNF-alpha mRNA expression, and interestingly inhibited LPS-induced NF-kappaB activation. Our data suggest that cloricromene protects rats from LPS by blocking LPS-induced NF-kappaB activation, leading to inhibition of NO and TNF-alpha overproduction and thereby reversing the LPS-induced vascular hyporeactivity.
Asunto(s)
Cromonar/análogos & derivados , Cromonar/uso terapéutico , Endotoxemia/tratamiento farmacológico , FN-kappa B/antagonistas & inhibidores , Salmonella typhi , Animales , Aorta Torácica/efectos de los fármacos , Aorta Torácica/metabolismo , Aorta Torácica/fisiología , Ensayo de Cambio de Movilidad Electroforética , Endotoxemia/metabolismo , Endotoxemia/fisiopatología , Técnicas In Vitro , Masculino , Contracción Muscular/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/fisiología , FN-kappa B/genética , FN-kappa B/metabolismo , Nitratos/sangre , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa de Tipo II , Nitritos/sangre , Fenilefrina , ARN Mensajero/antagonistas & inhibidores , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/genéticaRESUMEN
Two ethanolic propolis extracts (EPE) with and without the caffeic acid phenethyl ester (CAPE), CAPE and galangin (major components of propolis) were investigated for anti-inflammatory activity in rats using carrageenin foot oedema, carrageenin pleurisy and adjuvant arthritis. In our experiments, EPE with CAPE and CAPE alone significantly inhibited carrageenin oedema, carrageenin pleurisy and adjuvant arthritis. In contrast EPE without CAPE and galangin did not exhibit anti-inflammatory effects in acute and chronic inflammation. These results suggest that the anti-inflammatory activity of propolis is due to CAPE.
Asunto(s)
Antiinflamatorios/farmacología , Artritis/prevención & control , Edema/prevención & control , Alcohol Feniletílico/análogos & derivados , Fitoterapia , Pleuresia/prevención & control , Própolis/farmacología , Enfermedad Aguda , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/química , Antiinflamatorios/uso terapéutico , Artritis/inducido químicamente , Ácidos Cafeicos/administración & dosificación , Ácidos Cafeicos/química , Ácidos Cafeicos/farmacología , Ácidos Cafeicos/uso terapéutico , Carragenina , División Celular/efectos de los fármacos , Enfermedad Crónica , Edema/inducido químicamente , Flavonoides/administración & dosificación , Flavonoides/química , Flavonoides/farmacología , Flavonoides/uso terapéutico , Masculino , Alcohol Feniletílico/administración & dosificación , Alcohol Feniletílico/química , Alcohol Feniletílico/farmacología , Alcohol Feniletílico/uso terapéutico , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Pleuresia/inducido químicamente , Própolis/administración & dosificación , Própolis/química , Própolis/uso terapéutico , Ratas , Ratas Endogámicas Lew , Ratas Wistar , Linfocitos T/efectos de los fármacos , Factores de TiempoRESUMEN
In this study, using rat carrageenin-induced pleurisy, we found that treatment of rats with either indomethacin or NS-398 suppressed the pleurisy at 2 h but significantly exacerbated this reaction at 48 h. Exacerbated inflammation was associated with reduced prostaglandin D(2) levels, decreased heat shock factor 1 (HSF1) activation, reduced hsp72 expression and increased activation of nuclear factor kappaB (NF-kappaB). Replacement of cyclopentenone prostaglandins by treating rats with either prostaglandin J(2) or prostaglandin D(2) reversed the exacerbating effects of cyclooxygenase inhibitors leading to the resolution of the reaction. In conclusion, we demonstrate that cyclopentenone prostaglandins may act as anti-inflammatory mediators by inducing in inflammatory cells HSF1-dependent hsp72 expression and NF-kappaB inhibition, two crucial events for the remission of inflammation.
Asunto(s)
Proteínas de Choque Térmico/metabolismo , FN-kappa B/metabolismo , Pleura/metabolismo , Pleuresia/metabolismo , Prostaglandina D2/análogos & derivados , Prostaglandina D2/farmacología , Prostaglandinas/metabolismo , Transporte Activo de Núcleo Celular/efectos de los fármacos , Animales , Carragenina , Inhibidores de la Ciclooxigenasa/farmacología , Proteínas de Unión al ADN/metabolismo , Modelos Animales de Enfermedad , Combinación de Medicamentos , Exudados y Transudados/química , Exudados y Transudados/citología , Proteínas del Choque Térmico HSP72 , Factores de Transcripción del Choque Térmico , Humanos , Indometacina/farmacología , Masculino , Subunidad p50 de NF-kappa B , Nitrobencenos/farmacología , Pleura/efectos de los fármacos , Pleuresia/inducido químicamente , Prostaglandina D2/metabolismo , Prostaglandinas/química , Ratas , Ratas Wistar , Sulfonamidas/farmacología , Factor de Transcripción ReIA , Factores de TranscripciónRESUMEN
In the present study we investigated in the reverse passive Arthus reaction elicited in the rat skin the anti-inflammatory effect of double-stranded oligodeoxynucleotides (ODN) with consensus nuclear factor-kappaB (NF-kappaB) sequence as transcription factor decoys (TFD) to inhibit NF-kappaB binding to native DNA sites. Local administration of wild-type-, but not mutant-decoy ODN, dose-dependently reduced both plasma leakage and neutrophil infiltration in rat skin. Molecular analysis performed on soft tissue obtained from rat skin demonstrated: (1) an inhibition of NF-kappaB/DNA binding activity; (2) a decreased nuclear level of p50 and p65 NF-kappaB subunits; (3) an inhibition of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) protein expression, two inflammatory enzymes transcriptionally controlled by NF-kappaB. Furthermore, SN-50, a cell-permeable peptide capable of inhibiting the nuclear translocation of NF-kappaB complexes, as well as ammonium pyrrolidine dithiocarbamate, an inhibitor of NF-kappaB activation, exhibited a similar profile of activity of decoy ODN. Our results indicate that decoy ODN, acting as an in vivo competitor for the transcription factor's ability to bind to cognate recognition sequence, may represent a novel strategy to modulate immune reactions.
Asunto(s)
Antioxidantes/farmacología , Reacción de Arthus/metabolismo , FN-kappa B/metabolismo , Piel/efectos de los fármacos , Tiocarbamatos/farmacología , Factores de Transcripción/farmacología , Análisis de Varianza , Animales , Ciclooxigenasa 2 , ADN/metabolismo , Interacciones Farmacológicas , Isoenzimas/antagonistas & inhibidores , Masculino , Prostaglandina-Endoperóxido Sintasas , Pirrolidinas/farmacología , Ratas , Ratas Wistar , Piel/metabolismoRESUMEN
In this study we have investigated the relationship between neointima formation and NF-kappaB activation in a model of endothelial denudation of rat carotid artery (balloon angioplasty) using the antioxidant pyrrolidine dithiocarbamate as inhibitor of NF-kappaB activation. Furthermore, we have correlated NF-kappaB activation to the expression of inducible isoforms of both nitric oxide synthase (iNOS) and cyclooxygenase (COX-2) in injured carotids. In control group a significant proliferation of neointima was observed 14 days after balloon angioplasty, which was correlated to an increase of NF-kappaB/DNA binding activity as well as p50/p65 nuclear levels compared to those observed in the carotids from naive or sham-operated rats. Furthermore, NF-kappaB activation was correlated to increased iNOS and COX-2, but not beta-actin, protein expression. Treatment of rats for 14 days with the antioxidant agent pyrrolidine dithiocarbamate (50, 100, 200 mg/kg per os and day) caused a significant inhibition of all the parameters assayed, except beta-actin protein expression. These results indicate that prevention of NF-kappaB activation may lead to the inhibition of neointima formation and suggest that antioxidant agents may have therapeutic relevance for the prevention of human restenosis.
Asunto(s)
Vasos Sanguíneos/lesiones , FN-kappa B/fisiología , Angioplastia de Balón , Animales , Antioxidantes/farmacología , Vasos Sanguíneos/efectos de los fármacos , Western Blotting , Arterias Carótidas/efectos de los fármacos , Arterias Carótidas/fisiología , Ciclooxigenasa 2 , Densitometría , Ensayo de Cambio de Movilidad Electroforética , Endotelio Vascular/efectos de los fármacos , Isoenzimas/biosíntesis , Masculino , FN-kappa B/antagonistas & inhibidores , Óxido Nítrico Sintasa/biosíntesis , Óxido Nítrico Sintasa de Tipo II , Pruebas de Precipitina , Antígeno Nuclear de Célula en Proliferación/metabolismo , Prostaglandina-Endoperóxido Sintasas/biosíntesis , Pirrolidinas/farmacología , Ratas , Ratas Wistar , Tiocarbamatos/farmacologíaRESUMEN
We investigated the occurrence and the role of HSF1 activation and inducible hsp72 expression in the carrageenin pleurisy in the rat. Molecular analysis performed on pleural cells collected from rat pleural cavity after carrageenin challenge revealed increased HSF1 activation and hsp72 expression. Moreover, local injection of a double-stranded oligodeoxynucleotide (ODN) containing the heat shock element sequence, acting as transcription factor decoy, exacerbated the inflammatory reaction. The exacerbation, induced by wild-type, but not by mutant ODN decoy, was associated to both inhibition of HSF1/DNA binding activity and reduction of hsp72 expression. In conclusion, this study shows that HSF1 activation and hsp72 expression both actually occur in acute inflammation and that the remission of the inflammatory reaction is tightly associated to the HSF1-dependent hsp72 expression, suggesting a a relevant role for the HSF1/hsp72 pathway as an endogenous anti-inflammatory system.
Asunto(s)
Proteínas de Unión al ADN/metabolismo , Proteínas de Choque Térmico/metabolismo , Pleuresia/metabolismo , Animales , Antiinflamatorios/metabolismo , Carragenina , ADN sin Sentido/farmacología , Proteínas de Unión al ADN/antagonistas & inhibidores , Proteínas de Unión al ADN/genética , Modelos Animales de Enfermedad , Exudados y Transudados/metabolismo , Expresión Génica/efectos de los fármacos , Proteínas del Choque Térmico HSP72 , Factores de Transcripción del Choque Térmico , Masculino , Pleuresia/inducido químicamente , Ratas , Ratas Wistar , Factores de Tiempo , Factores de TranscripciónRESUMEN
SV-IV is a basic, thermostable, secretory protein of low Mr (9758) that is synthesized by rat seminal vesicle (SV) epithelium under strict androgen transcriptional control. This protein is of obvious pharmacological interest because it has potent nonspecies-specific immunomodulatory, anti-inflammatory, and pro-coagulant activities. In evaluating the clinical relevance and the possible use in medicine of SV-IV, we became interested in the study of its structure-function relationships and aimed to identify in its polypeptide chain specific peptide fragments possessing the marked anti-inflammatory properties of the protein not associated with other biological activities (pro-coagulation and immunomodulation) typical of this molecule. By using two different experimental approaches (the fragmentation of the protein into peptide derivatives by chemical methods and the organic synthesis on solid phase of selected peptide fragments), data were obtained showing that in this protein: (a) the immunomodulatory activity is related to the structural integrity of the whole molecule; (b) the anti-inflammatory activity is located in the N-terminal region of the molecule, the 8-16 peptide fragment being the most active; (c) the identified anti-inflammatory peptide derivatives do not seem to possess pro-coagulant activity, even though this particular function has been located in the 1-70 segment of the molecule.
Asunto(s)
Antiinflamatorios/síntesis química , Fragmentos de Péptidos/síntesis química , Proteínas/química , Proteínas de Secreción de la Vesícula Seminal , Secuencia de Aminoácidos , Animales , Antiinflamatorios/química , Coagulantes/síntesis química , Coagulantes/química , Bromuro de Cianógeno/química , Inmunosupresores/síntesis química , Inmunosupresores/química , Masculino , Datos de Secuencia Molecular , Fragmentos de Péptidos/química , Ratas , Ratas WistarRESUMEN
The transcription factor nuclear factor-kappaB (NF-kappaB) plays a key role in the expression of several genes involved in the inflammatory process. In the present study we investigated in an acute model of inflammation, the carrageenin-induced hind paw edema, the anti-inflammatory effect of double stranded oligodeoxynucleotides (ODN) with consensus nuclear factor-kappaB (NF-kappaB) sequence as transcription factor decoys (TFD) to inhibit NF-kappaB binding to native DNA sites. Local administration of wild-type, but not mutant-ODN decoy, dose-dependently inhibited edema formation induced by carrageenin in rat paw. Molecular analysis performed on soft tissue obtained from inflamed paw demonstrated: (1) an inhibition of NF-kappaB DNA binding activity; (2) a decreased nuclear level of p50 and p65 NF-kappaB subunits; (3) an inhibition of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) protein expression, two inflammatory enzymes transcriptionally controlled by NF-kappaB. Furthermore, SN-50, a cell-permeable peptide capable of inhibiting the nuclear translocation of NF-kappaB complexes, exhibited a similar profile of activity of ODN decoy. Our results indicate for the first time that ODN decoy, acting as an in vivo competitor for the transcription factor's ability to bind to cognate recognition sequence, may represent a novel strategy to modulate acute inflammation.
Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Inflamación/prevención & control , FN-kappa B/genética , Oligonucleótidos/uso terapéutico , Enfermedad Aguda , Animales , Unión Competitiva , Carragenina , Ciclooxigenasa 2 , Inflamación/inducido químicamente , Inflamación/metabolismo , Isoenzimas/metabolismo , Masculino , FN-kappa B/metabolismo , Óxido Nítrico Sintasa/metabolismo , Prostaglandina-Endoperóxido Sintasas/metabolismo , Ratas , Ratas WistarRESUMEN
OBJECTIVE AND DESIGN: The role of nitric oxide (NO) on leucocyte migration has been investigated in rat carrageenin-induced pleurisy. MATERIAL: Male Wistar rats. TREATMENT: L-arginine, NOC-18 and aminoguanidine were administered subcutaneously 1 h prior to carrageenin injection. METHODS: Leucocyte accumulation into the pleural cavity was measured 4 h after carrageenin challenge. Statistical significance was calculated by Bonferroni test. RESULTS: L-arginine (10 mg/kg) or the NO donor NOC-18 (10 mg/kg), significantly inhibited leucocyte infiltration by 31% and 20% respectively (P<0.01). On the contrary, when these compounds were given at high doses (L-arginine 300 mg/kg; NOC-18 30 mg/kg), leucocyte accumulation was increased by 22% and 33% respectively (P<0.01). Aminoguanidine, a relatively selective inhibitor of the inducible NO synthase, depending on the dose, showed a biphasic effect on cell migration. Thus, at low doses (30 and 100 mg/kg), aminoguanidine increased (by 40% and 74% respectively, P< 0.01) leucocyte infiltration which was inhibited by 41% (P < 0.01) when the drug was given at high dose (300 mg/kg). CONCLUSIONS: These results suggest that in rat carrageenin-induced pleurisy NO primarily inhibits leucocyte migration.
Asunto(s)
Carragenina , Movimiento Celular/efectos de los fármacos , Leucocitos/fisiología , Óxido Nítrico/farmacología , Pleuresia/patología , Animales , Arginina/administración & dosificación , Arginina/farmacología , Presión Sanguínea , Inhibidores Enzimáticos/farmacología , Guanidinas/administración & dosificación , Guanidinas/farmacología , Masculino , Donantes de Óxido Nítrico/administración & dosificación , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II , Compuestos Nitrosos/administración & dosificación , Compuestos Nitrosos/farmacología , Pleura/patología , Derrame Pleural/patología , Derrame Pleural/fisiopatología , Pleuresia/inducido químicamente , Ratas , Ratas WistarRESUMEN
The effect of four macrolide antibiotics (roxithromycin, clarithromycin, erythromycin, and azithromycin) on the generation of some mediators and cytokines involved in the inflammatory process has been studied both in vivo and in vitro. Rat carrageenin pleurisy was used as a model of acute inflammation, and the macrolides were administered (10, 20, and 40 mg/kg p.o.) 1 h before the carrageenin challenge. Exudate volume and leukocyte accumulation were both dose-dependently reduced by roxithromycin, clarithromycin and erythromycin in either normal or adrenalectomized animals. Furthermore, in normal rats, prostaglandin (PG)E(2), nitrate plus nitrite, and tumor necrosis factor-alpha levels in pleural exudate were significantly reduced by these macrolides. Roxithromycin appeared more effective than erythromycin and clarithromycin, whereas azithromycin only slightly affected the inflammatory reaction. None of the macrolides were able to modify leukotriene B(4) exudate levels. In vitro experiments have shown that the four macrolides (5-80 microM) reduced in a concentration-dependent manner the production of 6-keto-PGF(1alpha), NO(2)(-), tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 by lipopolysaccharide-stimulated J774 macrophages. In J774 cells, the inhibition of 6-keto-PGF(1alpha) and NO(2)(-) production by roxithromycin and erythromycin was not dependent on direct inhibition of cyclooxygenase-2 and inducible nitric oxide synthase activity because it appears to be related to the inhibition of cyclooxygenase-2 and inducible nitric oxide synthase protein expression. In conclusion, the present study shows that macrolide antibiotics have anti-inflammatory activity, which likely depends on their ability to prevent the production of proinflammatory mediators and cytokines, and suggest that these agents, particularly roxithromycin, can exert therapeutic effects independently of their antibacterial activity.
Asunto(s)
Antibacterianos/farmacología , Antiinflamatorios/farmacología , 6-Cetoprostaglandina F1 alfa/biosíntesis , Adrenalectomía , Anestesia , Animales , Azitromicina/farmacología , Carragenina , Línea Celular , Claritromicina/farmacología , Ciclooxigenasa 2 , Citocinas/biosíntesis , Dinoprostona/metabolismo , Relación Dosis-Respuesta a Droga , Eritromicina/farmacología , Mediadores de Inflamación/metabolismo , Isoenzimas/metabolismo , Leucotrieno B4/metabolismo , Macrófagos/metabolismo , Ratones , Nitratos/metabolismo , Óxido Nítrico/biosíntesis , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II , Nitritos/metabolismo , Pleuresia/inducido químicamente , Pleuresia/prevención & control , Prostaglandina-Endoperóxido Sintasas/metabolismo , Ratas , Roxitromicina/farmacología , Factores de Tiempo , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
In the present study we used IL-6 knockout mice (IL-6KO) to evaluate the role of IL-6 in the inflammatory response caused by injection of carrageenan into the pleural space. Compared with carrageenan-treated IL-6 wild-type (IL-6WT) mice, carrageenan-treated IL-6KO mice exhibited a reduced degree of pleural exudation and polymorphonuclear cell migration. Lung myeloperoxidase activity and lipid peroxidation were significantly reduced in IL-6KO mice compared with those in IL-6WT mice treated with carrageenan. Immunohistochemical analysis for nitrotyrosine and poly(A)DP-ribose polymerase revealed a positive staining in lungs from carrageenan-treated IL-6WT mice. No positive staining for nitrotyrosine or PARS was found in the lungs of the carrageenan-treated IL-6KO mice. Staining of lung tissue sections obtained from carrageenan-treated IL-6WT mice with an anti-cyclo-oxygenase-2 Ab showed a diffuse staining of the inflamed tissue. Furthermore, expression of inducible nitric oxide synthase was found mainly in the macrophages of the inflamed lungs from carrageenan-treated IL-6WT mice. The intensity and degree of the staining for cyclo-oxygenase-2 and inducible nitric oxide synthase were markedly reduced in tissue sections obtained from carrageenan-treated IL-6KO mice. Most notably, the degree of lung injury caused by carrageenan was also reduced in IL-6KO mice. Treatment of IL-6WT mice with anti-IL-6 (5 microg/day/mouse at 24 and 1 h before carrageenan treatment) also significantly attenuated all the above indicators of lung inflammation. Taken together, our results clearly demonstrate that IL-6KO mice are more resistant to the acute inflammation of the lung caused by carrageenan injection into the pleural space than the corresponding WT mice.
Asunto(s)
Carragenina/toxicidad , Interleucina-6/fisiología , Pulmón/inmunología , Pulmón/patología , Pleuresia/inmunología , Animales , Células Cultivadas , Citocinas/biosíntesis , Daño del ADN/inmunología , Dinoprostona/metabolismo , Inducción Enzimática/genética , Inducción Enzimática/inmunología , Interleucina-6/antagonistas & inhibidores , Interleucina-6/deficiencia , Interleucina-6/genética , Leucotrieno B4/biosíntesis , Pulmón/efectos de los fármacos , Pulmón/enzimología , Macrófagos/enzimología , Macrófagos/patología , Masculino , Malondialdehído/metabolismo , Ratones , Ratones Noqueados , Nitratos/metabolismo , Óxido Nítrico/biosíntesis , Óxido Nítrico Sintasa/biosíntesis , Óxido Nítrico Sintasa de Tipo II , Peroxidasa/metabolismo , Pleura/inmunología , Pleura/metabolismo , Pleura/patología , Pleuresia/inducido químicamente , Pleuresia/genética , Pleuresia/patología , Poli(ADP-Ribosa) Polimerasas/metabolismo , Prostaglandina-Endoperóxido Sintasas/metabolismo , Prostaglandinas F/metabolismo , Tirosina/análogos & derivados , Tirosina/metabolismoRESUMEN
OBJECTIVE: The generation of 8-epiprostaglandin F2alpha (8-epi-PGF2alpha) by arachidonic acid (AA)- and lipopolysaccharide (LPS)- stimulated J774 macrophages has been investigated. MATERIAL: Murine monocyte/macrophage J774 cell line. METHODS: Cells were incubated with AA or LPS and the amount of 8-epi-PGF2alpha, 6-ketoprostaglandin F1alpha (6-keto-PGF1alpha) and prostaglandin E2 (PGE2) released in the incubation media measured by radioimmunoassay (RIA) or, in some experiments, by enzyme immunoassay (EIA). The effect of dexamethasone (DXM), cycloheximide (CXM) and 5,5 dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5H)-furanone (DFU), a cyclooxygenase-2 (COX-2) selective inhibitor, on LPS-induced generation of AA metabolites was assessed. RESULTS: AA induced a significant production of 6-ketoPGF1alpha and PGE2, whereas LPS caused a concentration- and time-dependent increase of 8-epi-PGF2alpha, 6-keto-PGF1alpha and PGE2. DXM (2 microM) as well as CXM (1 microM) significantly decreased (p<0.001; n = 4) the LPS-stimulated production of 8-epi-PGF2alpha (by 86% and 82%, respectively), 6-ketoPGF1alpha (by 78% and 74%, respectively) and PGE2 (by 83% and 78%, respectively). Immunostimulated production of AA metabolites was also inhibited by DFU (IC50 0.3+/-0.04 microM; 0.16 +/- 0.02 microM and 0.11 +/- 0.05 microM for 8-epi-PGF2alpha, 6-keto-PGF1alpha and PGE2, respectively. CONCLUSIONS: These results demonstrate the role of COX-2 in the generation of 8-epi-PGF2alpha by LPS-stimulated J774 macrophages. The relevance of these findings requires further elucidation.
Asunto(s)
Dinoprost/análogos & derivados , Isoenzimas/metabolismo , Lipopolisacáridos/farmacología , Activación de Macrófagos , Macrófagos/metabolismo , Prostaglandina-Endoperóxido Sintasas/metabolismo , 6-Cetoprostaglandina F1 alfa/biosíntesis , Animales , Ácido Araquidónico/farmacología , Línea Celular , Cicloheximida/farmacología , Ciclooxigenasa 2 , Dexametasona/farmacología , Dinoprost/metabolismo , Dinoprostona/biosíntesis , Glucocorticoides/farmacología , Ratones , Inhibidores de la Síntesis de la Proteína/farmacologíaRESUMEN
In this study we investigated the activation of nuclear factor-kappaB in the carrageenin-induced rat pleurisy. We found that nuclear factor-kappaB DNA binding activity, measured in inflammatory cells which migrated into the pleural cavity, was detectable at 3 and 6 h, markedly increased at 24 h and decreased at 48 h after induction of the inflammation. The increase in nuclear factor-kappaB DNA binding activity paralleled both exudate formation and leukocyte infiltration. Treatment of animals with pyrrolidine dithiocarbamate, an inhibitor of nuclear factor-kappaB activation, inhibited the nuclear factor-kappaB DNA binding activity as well as exudate formation and leukocyte infiltration. These results indicate that nuclear factor-kappaB is activated in the carrageenin-induced pleurisy and suggest that its inhibition may represent a novel strategy for the modulation of inflammatory response.
Asunto(s)
Carragenina/toxicidad , Proteínas de Unión al ADN/metabolismo , FN-kappa B/metabolismo , Pleuresia/inducido químicamente , Pirrolidinas/farmacología , Tiocarbamatos/farmacología , Animales , Movimiento Celular , Exudados y Transudados/metabolismo , Leucocitos/fisiología , Masculino , FN-kappa B/antagonistas & inhibidores , Ratas , Ratas Wistar , Factores de TiempoRESUMEN
We studied the role of nuclear factor-kappaB (NF-kappaB) on the tone and on the expression of inducible nitric oxide (NO) synthase, both evaluated in aortas from lipopolysaccharide-treated rats. Thoracic aorta rings from lipopolysaccharide-treated rats (4 mg/kg, i.p.), compared to those from naive animals, showed: (i) reduced contractility to phenylephrine, (ii) progressive loss in tone when contracted with phenylephrine, (iii) increased inducible NO synthase protein expression and NF-kappaB activation. Pyrrolidine dithiocarbamate (10, 30, 100 mg/kg, i.p.), an antioxidant inhibitor of NF-kappaB activation, dose dependently suppressed all these lipopolysaccharide-induced effects. These results demonstrate that in vivo inhibition of NF-kappaB activation prevented the lipopolysaccharide-induced loss of vascular tone, an effect which was correlated to reduced expression of inducible NO synthase protein.
Asunto(s)
Lipopolisacáridos/farmacología , Relajación Muscular/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , FN-kappa B/antagonistas & inhibidores , Óxido Nítrico Sintasa/genética , Pirrolidinas/farmacología , Tiocarbamatos/farmacología , Animales , Técnicas In Vitro , Masculino , FN-kappa B/metabolismo , Óxido Nítrico Sintasa de Tipo II , Fenilefrina/farmacología , Ratas , Ratas WistarRESUMEN
We studied the involvement of nuclear factor-kappaB (NF-kappaB) in the regulation of inducible nitric oxide synthase expression in carrageenin-induced rat pleurisy. Injection of 0.2 ml of 1% lambda-carrageenin into the pleural cavity of male Wistar rats caused after 6 h: (a) exudate formation and leukocyte migration into the pleural cavity; (b) inducible NO synthase protein expression and accumulation of NO2- plus NO3- in pleural exudate; (c) increase in p50/p65 nuclear level as well as NF-kappaB/DNA binding activity. Treatment of rats with pyrrolidine dithiocarbamate (10, 30, and 100 mg/kg) and N-alpha-p-tosyl-L-lysine chloromethylketone (30 mg/kg), two inhibitors of NF-kappaB activation, given subcutaneously concomitantly with carrageenin, caused a significant inhibition of all the parameters assayed. These results suggest that in carrageenin-induced rat pleurisy the activation of NF-kappaB plays a key role in inducible NO synthase protein expression and in the development of inflammatory response.
Asunto(s)
FN-kappa B/genética , FN-kappa B/metabolismo , Óxido Nítrico Sintasa/biosíntesis , Pleuresia/enzimología , Animales , Antioxidantes/farmacología , Carragenina , Movimiento Celular/efectos de los fármacos , Núcleo Celular/metabolismo , ADN/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Electroforesis en Gel de Poliacrilamida , Exudados y Transudados/citología , Exudados y Transudados/efectos de los fármacos , Recuento de Leucocitos/efectos de los fármacos , Leucocitos/citología , Leucocitos/efectos de los fármacos , Leucocitos/metabolismo , Masculino , FN-kappa B/antagonistas & inhibidores , FN-kappa B/efectos de los fármacos , Subunidad p50 de NF-kappa B , Nitratos/metabolismo , Óxido Nítrico Sintasa/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo II , Nitritos/metabolismo , Derrame Pleural/inducido químicamente , Derrame Pleural/citología , Pleuresia/inducido químicamente , Pirrolidinas/farmacología , Ratas , Ratas Wistar , Inhibidores de Serina Proteinasa/farmacología , Tiocarbamatos/farmacología , Clorometilcetona Tosilisina/farmacología , Factor de Transcripción ReIARESUMEN
The role of nitric oxide (NO) in the reverse passive Arthus reaction elicited in the rat skin has been studied. The reverse passive Arthus reaction was modulated by test compounds given by intradermal injection in combination with anti-bovine serum albumin antibody. L-arginine (1.5-15 micromol/site) and the NO donor [1-hydroxy-2-oxo-3,3-bis (3-amonoethyl)- 1-triazenel (NOC-18; 1-10 micromol/site) both significantly reduced neutrophil infiltration and increased plasma leakage. The NO scavenger haemoglobin (30 and 100 micromol/site) did not affect oedema formation but increased neutrophil infiltration and attenuated the effects of L-arginine. The non-selective nitric oxide synthase inhibitors N(G)-nitro-L-arginine methyl ester (0.3-100 nmol/site) and N(G)-monomethyl-L-arginine (0.3-100 nmol/site) or the relatively selective inhibitors of the inducible NO synthase aminoguanidine (30-1000 nmol/site) and S-methylthiourea (3-1000 nmol/site) significantly reduced plasma leakage when given at high doses. Furthermore all these inhibitors exhibited a dose-related biphasic effect on neutrophil infiltration which was significantly increased by low doses and reduced by high doses, while intermediate doses had no effect. Phenylpropanolamine, a sympathomimetic vasoconstrictor (15-60 micromol/site), dose-dependently reduced both oedema formation and neutrophil infiltration. These results provide evidence for a relevant role of NO as a modulator of rat dermal reverse passive Arthus reaction and suggest that at the vascular level NO controls primarily the interaction between leucocyte and endothelial cell rather than the vascular permeability.
Asunto(s)
Reacción de Arthus/etiología , Neutrófilos/fisiología , Óxido Nítrico/fisiología , Animales , Permeabilidad Capilar , Guanidinas/farmacología , Hemoglobinas/farmacología , Masculino , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/fisiología , Compuestos Nitrosos/farmacología , Ratas , Ratas WistarRESUMEN
The correlation between endogenous nitric oxide (NO) generation and prostaglandin biosynthesis was studied in rat carrageenin pleurisy induced by the injection of 0.2 mL of 1% lambda-carrageenin into the pleural cavity. The pleural exudate was collected at 4 hr and the amounts of NO2- + NO3- (NOx) and prostaglandin E2 (PGE2) measured. The NOx present in the inflammatory exudate was determined by measuring the NO2- with the Griess reaction, after the reduction of NO3- to NO2- using acid-washed cadmium powder. PGE2 was measured by radioimmunoassay. The NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 1-3-10 mg/kg subcutaneously) reduced NOx by 20 +/- 7%, 41 +/- 6% and 55 +/- 9% (P < 0.01) and PGE2 by 9 +/- 6%, 41 +/- 11% and 74 +/- 9% (P < 0.001). Conversely, L-arginine (300 mg/kg SC) increasedNOx by 39 +/- 7% (P < 0.01) and PGE2 by 78 +/- 6% (P < 0.001). The NO scavenger haemoglobin (Hb), coinjected into the pleural cavity (3 mg/site) with carrageenin, produced a parallel inhibition of NOx (65 +/- 16%, P < 0.001) and PGE2 (71 +/- 18%, P < 0.001). The soluble guanylate cyclase inhibitor methylene blue (Mb; 2 mg/site) had no effect. Moreover haemoglobin, but not methylene blue, was able to significantly suppress the L-arginine-induced increase of both NOx and PGE2. In each pleural exudate, independently from the animal treatment, the amount of NOx was highly correlated to the amount of PGE2 (r = 0.93, P < 0.001). These results suggest that in rat carrageenin pleurisy the modulation of the L-arginine:NO pathway results in a parallel modulation of prostaglandin biosynthesis. The interaction between cyclooxygenase and the NO pathway may represent an important mechanism for the modulation of the inflammatory response.
Asunto(s)
Óxido Nítrico/metabolismo , Pleuresia/inducido químicamente , Pleuresia/metabolismo , Prostaglandinas/metabolismo , Animales , Carragenina , Inhibición de Migración Celular , Dinoprostona/biosíntesis , Inhibidores Enzimáticos/farmacología , Exudados y Transudados/citología , Exudados y Transudados/efectos de los fármacos , Leucocitos/efectos de los fármacos , Masculino , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/biosíntesis , Radioinmunoensayo , Ratas , Ratas WistarRESUMEN
Glucocorticoids inhibit inducible-type NO synthase activity in a variety of cell types. We report here that proteins recovered from the medium of dexamethasone-treated J774 macrophages (1, 10, 100 microg/ml) inhibited lipopolysaccharide-stimulated nitrite generation by 10.0 +/- 3.0%, 32.3 +/- 5.3% and 55.0 +/- 6.0%, respectively, and inducible NO synthase mRNA expression in these cells. Immunoblotting analysis of crude and partially purified glucocorticoid-induced proteins with an anti-lipocortin-1 polyclonal antiserum revealed the presence of lipocortin-1-like immunoreactive species with a molecular mass of 35-37 kDa. Furthermore, inhibition of lipopolysaccharide-induced nitrite production by glucocorticoid-induced proteins in J774 cells was reversed by addition of anti-lipocortin-1 neutralizing polyclonal antibody (1:60 dilution; 4 h before lipopolysaccharide). Comparison of glucocorticoid-induced proteins inhibition of both nitrite production and inducible NO synthase mRNA expression suggests that these effects result mainly from inhibition of lipopolysaccharide-mediated inducible NO synthase gene expression. These results indicate that negative regulation of inducible NO synthase by glucocorticoids is, at least in part, mediated by glucocorticoid-induced proteins that involve also members of the lipocortin-like superfamily.
Asunto(s)
Dexametasona/farmacología , Regulación Enzimológica de la Expresión Génica/fisiología , Glucocorticoides/farmacología , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Óxido Nítrico Sintasa/genética , Animales , Anexina A1/inmunología , Células Cultivadas , Medios de Cultivo Condicionados , Inducción Enzimática , Immunoblotting , Ratones , Óxido Nítrico Sintasa de Tipo II , Nitritos/metabolismo , Estimulación QuímicaRESUMEN
To obtain information about the structure-activity relationships of analgesic peptides, we modified the previously reported tripeptide, H-Lys-Pro-Thr-OH (C). The proline part in C was replaced with various analogues of unconventional amino acids [(3aS, 7aS)-octahydroindole-2-carboxylic acid (Oic), (S,S,S,)-2-azabiciclo [3.3.0]octane-3-carboxylic acid (Aoc), D-Aoc, and (2S, 4R)-hydroxyproline (Hyp)] with varying lipophilic, steric, and conformational properties, and alternatively with Lys and Orn in the lysine part. Moreover, the threonine part was changed to various natural amino acids (Ser, Thr, Val, Leu). All the compound were screened in vivo for their analgesic effects in mouse writhing test. Compound 24 (H-Orn-Hyp-Val-OH), the most active compound within the series, showed an ED50 value of 10 mg/kg, which is comparable with the ED50 values exhibited by indometacin (4.1 mg/kg) and the dipeptide H-Lys-D-Pro-OH (6.9 mg/kg), both used as reference drugs.